Blood Group Genotyping - 09/11/22
Doi : 10.1016/j.cll.2022.09.016
Jensyn K. Cone Sullivan, MD a, b, Nicholas Gleadall, PhD c, William J. Lane, MD, PhD d, e, ⁎ 
a Department of Pathology, The Neely Cell Therapy Center, Tufts Medical Center, 800 Washington Street, #826, Boston, MA 02111, USA
b Tufts University School of Medicine, Boston, MA, USA
c Department of Haematology, University of Cambridge, University of Cambridge Biomedical Campus, Long Road, Cambridge, CB2 0PT, UK
d Department of Pathology, Brigham and Women’s Hospital, Hale Building for Transformative Medicine, Room 8002L, 60 Fenwood Road, Boston, MA 02115, USA
e Harvard Medical School, Boston, MA, USA
∗Corresponding author. Department of Pathology, Brigham and Women’s Hospital, Hale Building for Transformative Medicine, Room 8002L, 60 Fenwood Road, Boston, MA 02115.Department of PathologyBrigham and Women’s HospitalHale Building for Transformative MedicineRoom 8002L60 Fenwood RoadBostonMA02115
Keywords : Next generation sequencing, Red blood cells, Erythrocyte antigens, Blood groups, Blood group antigens, Array, Genomics
Plan
| This article originally appeared in Advances in Molecular Pathology, Volume 4, Issue 1, November 2021. |
© 2022
Elsevier Inc. Tous droits réservés.
Vol 42 - N° 4
P. 645-668 - décembre 2022 Retour au numéro
Article précédent
- The Role of the Human Gutome on Chronic Disease : A Review of the Microbiome and Nutrigenomics
- Carrie C. Hoefer, Leah K. Hollon, Jennifer A. Campbell
- Cell-free Nucleic Acids in Cancer : Current Approaches, Challenges, and Future Directions
- Liron Barnea Slonim, Kathy A. Mangold, Mir B. Alikhan, Nora Joseph, Kalpana S. Reddy, Linda M. Sabatini, Karen L. Kaul
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?